Non-specific low back pain (NSLBP) is a prevalent condition affecting up to 84% of the adult population, frequently progressing to chronicity and diminishing quality of life. Interferential current (IFC) therapy has demonstrated effectiveness in alleviating musculoskeletal pain using 2KHz and 4KHz carrier frequencies, though conventional treatment protocols require sessions of 30 minutes or longer. The integration of IFC with ultrasound technology enables deeper tissue penetration and significan
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male or female, 2. Age between 18 40 years, 3 Has chronic low back pain of nonspecific cause for more than 12 weeks, 4 Has pain in the lower back area which may or may not be accompanied by radiating pain down the leg, 5 Body mass index is within normal range, with BMI between 18.50-24.99 kg per meter square -Has pain level when assessed with numeric rating scale scoring between 4 to 7 points
Exclusion criteria
Exclusion criteria: 1. Has been diagnosed with disc herniation, 2. Has abnormal skin sensation such as numbness or feeling of pins and needles, 3. Has no lower back pain on the day of assessment before beginning the study. 4, Has used pain medication, anti-inflammatory drugs, or muscle relaxants within 24 hours before treatment, 5. Has a history of bone fracture and/or previous surgery in the spine or leg area, 6. Has been diagnosed with specific causes of lower back pain including: infection, metastasis, osteoporosis, rheumatoid arthritis, 7. Has cauda equina syndrome (inability to control urination or defecation, or incomplete urination or defecation), 8. Female who is pregnant or breastfeeding, 9. Has contraindications for electrical and ultrasound therapy including: metal implants in the spine and/or thigh, use of pacemaker, skin disease in the back area, open wound in the back area, impaired communication, deep vein thrombosis or thrombophlebitis, malignancy, radiation therapy within the past 3 months, infection, impaired circulation, or tuberculosis, 10. Has neuromuscular disease such as fibromyalgia, spinal muscular atrophy (SMA), etc., 11. Is currently receiving treatment for chronic lower back pain of unclear cause, 12. Has a history of brain and/or spinal cord injury
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity at baseline, immediately after 1st treatment, post-treatment, and one-month follow-up periods Numeric rating scale (NRS) | — |
Secondary
| Measure | Time frame |
|---|---|
| Lumbar ROM at baseline, immediately after 1st treatment, post-treatment, and one-month follow-up periods Modified Modified Schober's test (MMST) using tape measurement in cm.,Joint position sense at baseline, immediately after 1st treatment, post-treatment, and one-month follow-up periods Joint position sense error (distance of error in cm.)),Self-rated functional disability at baseline, post-treatment, and one-month follow-up periods Oswestry disability questionnaires (score) which is rated by participants,Self-rated functional disability at baseline, post-treatment, and one-month follow-up periods Roland Morris Disability Questionnaire which is rated by participants | — |
Countries
Thailand
Contacts
Faculty of Associated Medical Sciences, Khon Kaen University